Dietary intervention with HMOS in vivo has shown to significantly reduce diabetes incidence, possibly through reducing the induction of diabetogenic cytokines such as IL‐17 and IFN‐γ in a NOD‐mice model 43. This evidence concerns the gene IFNG and diabetes mellitus.